Skip Navigation


Carcinogenesis Advance Access originally published online on February 20, 2006
Carcinogenesis 2006 27(6):1169-1179; doi:10.1093/carcin/bgi363
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
27/6/1169    most recent
bgi363v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Méndez, O.
Right arrow Articles by Sierra, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Méndez, O.
Right arrow Articles by Sierra, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Underexpression of transcriptional regulators is common in metastatic breast cancer cells overexpressing Bcl-xL

Olga Méndez, Berta Martín, Rebeca Sanz, Ramón Aragüés 1, Victor Moreno 2, Baldo Oliva 1, Verena Stresing and Angels Sierra *

Centre d'Oncologia Molecular, Institut de Recerca Oncológica, IDIBELL, Hospital Duran i Reynals, Gran Via s/n, Km 2,7, E-08907 L'Hospitalet Ll., Barcelona 1 Grup de Bioinformàtica Estructural (GRIB-IMIM). Universitat Pompeu Fabra. C/Doctor Aiguader, 80, Barcelona 08003, Catalonia and 2 Servei d'Epidemiologia Institut Català d'Oncologia and Laboratorio de Bioestadística y Epidemiologia, Universitat Autónoma de Barcelona, Hospital Duran i Reynals, Gran Via s/n, Km 2,7, L'Hospitalet Ll. 08907, Spain

* To whom correspondence should be addressed. Tel: +34 93 2607429; Fax: +34 93 260 7426; Email: asierra{at}iro.es

Bcl-xL gene induces metastasis in the lung, lymph nodes and bone when breast cancer cells are inoculated in Nude Balb/c mice. In an attempt to identify the molecules required for diverse metastatic foci, we compared gene expression levels in tumor cells and metastatic variants with a cDNA GeneFilter containing 4000 known genes. The transcriptional regulators of {alpha}1-fetoprotein transcription factor, TBP-associated factor 172 (TAF-172) and the human zinc finger protein 5 (ZFP5) were downregulated. The expression of TAF-172 was inversely proportional to Bcl-xL expression (ANOVA P < 0.0001) and metastatic activity (ANOVA P < 0.0001). A protein interaction program allowed us to functionally associate Bcl-xL and TAF through TATA-binding protein (TBP), suggesting that Bcl-xL connects metabolic pathways with transcriptional machinery. The prediction included proteins involved in apoptosis, electron transfer, kinases and transcription factors. These results indicate that the selection of diverse metastatic cells from the broad spectrum of tumor cell leads to the underexpression of certain transcriptional regulators that might act as adaptor molecules to different microenvironments, and indicate that the synergistic activity of several genes is needed for the selection process in several metastatic foci.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.